The potential role of bacterial metabolic toxins in the development of diabetes

Irritable bowel syndrome is one of the most common problems reported to general practitioners and gastroenterologists. It has been shown that many of the gut and systemic symptoms are due to lactose sensitivity, the sugar found mainly in milk. Undigested carbohydrates and other foods absorbed by the...

Full description

Bibliographic Details
Main Author: Vassel, Nasrin
Published: Cardiff University 2012
Subjects:
Online Access:http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.567496
id ndltd-bl.uk-oai-ethos.bl.uk-567496
record_format oai_dc
spelling ndltd-bl.uk-oai-ethos.bl.uk-5674962015-03-20T03:21:53ZThe potential role of bacterial metabolic toxins in the development of diabetesVassel, Nasrin2012Irritable bowel syndrome is one of the most common problems reported to general practitioners and gastroenterologists. It has been shown that many of the gut and systemic symptoms are due to lactose sensitivity, the sugar found mainly in milk. Undigested carbohydrates and other foods absorbed by the small intestine reach the bacteria in the large intestine. There is little oxygen here, the bacteria metabolise these to produce gases such as hydrogen and methane, and a variety of small organic metabolites such as methylglyoxal. These metabolites are absorbed into the bloodstream and can affect tissues around the body. The overall aim of this thesis was to investigate the potential role of the bacterial metabolic toxin hypothesis in the development of diabetes. To specifically investigate the ability of these toxins to covalently modify proteins and to investigate the biological activity of these modified proteins on glucose uptake and cell differentiation. Albumin and insulin have been shown to exhibit mono-oxygenase activity demonstrated by coelenterazine chemiluminescence. It was heat denaturable, demonstrated saturable substrate characteristics, was inhibited or activated by cations (Fe2+, Fe3+, Zn2+ and Ca2+) known to bind to these proteins and was inhibited by drugs that are known to bind to Sudlow’s site I on albumin. The inhibition of albumin catalysed coelenterazine chemiluminescence observed in the presence of drugs that are known to bind to Sudlow’s site I on albumin proposes that this is also the coelenterazine binding site. Molecular 3D modelling confirmed that coelenterazine binds to this site. Methylglyoxal covalently modified these proteins resulting in reduced biological activity. Tetraethylammonium significantly inhibited 3T3-L1 cell differentiation in the presence of insulin. However, methylglyoxal and tetrandrine did not significantly inhibit 3T3-L1 cell differentiation. The results in this thesis support the hypothesis that bacterial metabolic toxins can covalently modify proteins and alter their biological activity.616.3Q Science (General)Cardiff Universityhttp://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.567496http://orca.cf.ac.uk/43332/Electronic Thesis or Dissertation
collection NDLTD
sources NDLTD
topic 616.3
Q Science (General)
spellingShingle 616.3
Q Science (General)
Vassel, Nasrin
The potential role of bacterial metabolic toxins in the development of diabetes
description Irritable bowel syndrome is one of the most common problems reported to general practitioners and gastroenterologists. It has been shown that many of the gut and systemic symptoms are due to lactose sensitivity, the sugar found mainly in milk. Undigested carbohydrates and other foods absorbed by the small intestine reach the bacteria in the large intestine. There is little oxygen here, the bacteria metabolise these to produce gases such as hydrogen and methane, and a variety of small organic metabolites such as methylglyoxal. These metabolites are absorbed into the bloodstream and can affect tissues around the body. The overall aim of this thesis was to investigate the potential role of the bacterial metabolic toxin hypothesis in the development of diabetes. To specifically investigate the ability of these toxins to covalently modify proteins and to investigate the biological activity of these modified proteins on glucose uptake and cell differentiation. Albumin and insulin have been shown to exhibit mono-oxygenase activity demonstrated by coelenterazine chemiluminescence. It was heat denaturable, demonstrated saturable substrate characteristics, was inhibited or activated by cations (Fe2+, Fe3+, Zn2+ and Ca2+) known to bind to these proteins and was inhibited by drugs that are known to bind to Sudlow’s site I on albumin. The inhibition of albumin catalysed coelenterazine chemiluminescence observed in the presence of drugs that are known to bind to Sudlow’s site I on albumin proposes that this is also the coelenterazine binding site. Molecular 3D modelling confirmed that coelenterazine binds to this site. Methylglyoxal covalently modified these proteins resulting in reduced biological activity. Tetraethylammonium significantly inhibited 3T3-L1 cell differentiation in the presence of insulin. However, methylglyoxal and tetrandrine did not significantly inhibit 3T3-L1 cell differentiation. The results in this thesis support the hypothesis that bacterial metabolic toxins can covalently modify proteins and alter their biological activity.
author Vassel, Nasrin
author_facet Vassel, Nasrin
author_sort Vassel, Nasrin
title The potential role of bacterial metabolic toxins in the development of diabetes
title_short The potential role of bacterial metabolic toxins in the development of diabetes
title_full The potential role of bacterial metabolic toxins in the development of diabetes
title_fullStr The potential role of bacterial metabolic toxins in the development of diabetes
title_full_unstemmed The potential role of bacterial metabolic toxins in the development of diabetes
title_sort potential role of bacterial metabolic toxins in the development of diabetes
publisher Cardiff University
publishDate 2012
url http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.567496
work_keys_str_mv AT vasselnasrin thepotentialroleofbacterialmetabolictoxinsinthedevelopmentofdiabetes
AT vasselnasrin potentialroleofbacterialmetabolictoxinsinthedevelopmentofdiabetes
_version_ 1716780307828441088